Landscapes / Companies
ModeX Therapeutics, An OPKO Health Company not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
1 in Phase 1
Drugs
4
in active trials
Trials
4 active
4 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Jan 2028Phase 1/2 trial completes | |||
| Next date | Jan 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Lymphoma, Waldenström Macroglobulinemia (WM) and 6 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Aug 2028Phase 1/2 trial completes | |||
| Next date | Aug 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Biliary Tract Cancer, Breast Cancer and 19 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Jun 2031Phase 1/2 trial completes | |||
| Next date | 30 Jun 2031 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | Sep 2027Phase 1 trial completes | |||
| Next date | Sep 2027 · Phase 1 trial completes | ||||
| Also tested for | COVID -19, COVID-19 (Prevention) | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021